[News] UK NHS to enrol thousands in trials of personalised mRNA cancer vaccines

June, 06, 2024 | Select Oncology Journal Articles

The UK’s National Health Service (NHS)—in partnership with biotechnology company BioNTech SE and hospitals across the country—is to grant thousands of patients with cancer in England fast-track access to trials of personalised cancer vaccines.

For Additional News from OncWeekly – Your Front Row Seat To The Future of Cancer Care –




Sign up for our emails

Trusted insights straight to your inbox and get the latest updates from OncWeekly

Privacy Policy